Edition:
United States

Aptose Biosciences Inc (APTO.OQ)

APTO.OQ on NASDAQ Stock Exchange Capital Market

1.83USD
15 Dec 2017
Change (% chg)

$0.08 (+4.57%)
Prev Close
$1.75
Open
$1.80
Day's High
$1.88
Day's Low
$1.76
Volume
27,131
Avg. Vol
43,523
52-wk High
$2.29
52-wk Low
$0.78

Chart for

About

Aptose Biosciences Inc. (Aptose) is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and signal transduction abnormalities that underlie a particular life-threatening malignancy. Its product pipeline includes cancer drug candidates... (more)

Overall

Beta: 2.21
Market Cap(Mil.): $48.64
Shares Outstanding(Mil.): 26.50
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

BRIEF-Aptose Biosciences Inc Q3 loss per share C$0.14

* Aptose reports results for the third quarter ended September 30, 2017

Nov 14 2017

BRIEF-Aptose enters into $15.5 mln common shares purchase agreement with Aspire Capital Fund, Llc

* Aptose enters into $15.5 million common shares purchase agreement with Aspire Capital Fund, Llc

Oct 30 2017

BRIEF-Aptose Biosciences Inc qtrly earnings per share $0.15

* Aptose reports results for the second quarter ended June 30, 2017

Aug 08 2017

Earnings vs. Estimates